Concentration dependent mitochondrial effect of amiodarone

Biochemical Pharmacology

Volumn 65, Issue 7, 2003, Pages 1115-1128

  Varbiro, Gabor ^a   Toth, Ambrus ^a   Tapodi, Antal ^a   Veres, Balazs ^a   Sumegi, Balazs ^a   Gallyas Jr , Ferenc ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

31P NMR; Amiodarone; High energy phosphates; Langendorff perfused heart; Mitochondria; Permeability transition

Indexed keywords

AMIODARONE; CALCIUM ION; CYCLOSPORIN A; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENERGY METABOLISM; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; ISCHEMIA; ISOLATED HEART; LIVER CELL; MITOCHONDRION; NONHUMAN; PANCREAS CELL; PERMEABILITY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

EID: 0344951247     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01660-X     Document Type: Article

References (44)

1. Singh B.N., Vaughan Williams E.M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br. J. Pharmacol. 39:1970;657-667.
2. Nokin P., Clinet M., Schoenfeld P. Cardiac β-adenoreceptor modulation by amiodarone. Biochem. Pharmacol. 32:1983;2473-2477.
3. Nattel S., Talajic M., Quantz M., DeRoode M. Frequency-dependent effect of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity. Circulation. 76:1987;442-449.
4. Varro A., Virag L., Papp J.G. Comparison of the chronic and acute effect of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes. Br. J. Pharmacol. 117:1996;1181-1186.
5. Amico J.A., Richardon V., Alpert B., Klein I. Clinical and chemical assessment of thyroid function during therapy with amiodarone. Arch. Intern. Med. 144:1984;487-490.
6. Martin W.J., Howard D.M. Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug. Am. J. Pathol. 120:1985;344-350.
7. Moreau D., Clauw F., Martine L., Grynberg A., Rochette L., Demaison L. Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion. Mol. Cell Biochem. 194:1999;291-300.
8. Remme W.J., van Hoogenhuyze D.C. Hemodynamic profile of amiodarone during acute and long-term administration in patients with ventricular dysfunction. Cardioscience. 1:1990;169-176.
9. Ellenbogen K.A., O'Callaghan W.G., Colavita P.G., Smith M.S., German L.D. Cardiac function in patients on chronic amiodarone therapy. Am. Heart J. 110:1985;376-381.
10. Karlson J.A., Hopkins R.W., Moran J.M., Karlson K.E. Long-term amiodarone administration protects against global myocardial ischemia. Ann. Thorac. Surg. 50:1990;575-578.
11. Vander-Elst L., Goudemant J.F., Mouton J., Chatelain P., Van Haverbeke Y., Muller R.N. Amiodarone pretreatment effects on ischemic isovolumic rat hearts: a P-31 nuclear magnetic resonance study of intracellular pH and high-energy phosphates contents evolutions. J. Cardiovasc. Pharmacol. 15:1990;377-385.
12. Ribeiro S.M., Campello A.P., Nascimento A.J., Kluppel M.L. Effect of amiodarone (AMD) on the antioxidant enzymes, lipid peroxidation and mitochondrial metabolism. Cell Biochem. Funct. 15:1997;145-152.
13. Card J.W., Lalonde B.R., Rafeiro E., Tam A.S., Racs W.J., Brien J.F., Bray T.M., Massey T.E. Amiodarone-induced disruption of hamster lung and liver mitochondrial function: lack of association with thiobarbituric acid-reactive substance production. Toxicol. Lett. 98:1998;41-50.
14. Dzimiri N., Almotrefi A.A. Actions of amiodarone on mitochondrial ATPase and lactate dehydrogenase activities in guinea pig preparations. Eur. J. Pharmacol. 242:1993;113-118.
15. Nokin P., Jungbluth L., Mouton J. Protective effects of amiodarone pretreatment on mitochondrial function and high-energy phosphates in ischemic rat heart. J. Mol. Cell Cardiol. 19:1987;603-614.
16. Kennedy J.A., Unger S.A., Horowitz J.D. Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Biochem. Pharmacol. 52:1996;273-280.
17. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
18. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
19. Szabados E., Fisher M.G., Gallyas F., Kispal G.Y., Sumegi B. Enhanced ADP-ribosylation and its diminition by lipoamide following ischemia-reperfusion in perfused rat heart. Free Radic. Biol. Med. 27:1999;1103-1113.
20. Gorczyca W., Gong J., Ardelt B., Traganos F., Darzynkiewicz Z. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 139:1991;271-277.
21. Schneider W.C., Hageboom G.H. Further studies on the distribution of cytochrome c in rat liver homogenates. J. Biol. Chem. 183:1950;123-128.
22. Sims N.R. Rapid isolation on metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation. J. Neurochem. 55:1990;698-707.
23. Elimadi A., Morin D., Albengres E., Chauvet-Monges A.M., Allain V., Crevat A., Tillement J.P. Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorilation. Br. J. Pharmacol. 121:1997;1295-1300.
24. 2+ involvement in the mitochondrial response of cultured fetal rat hepatocytes to adrenaline. Exp. Cell Res. 237:1997;403-409.
25. D'Aurelio M., Pallotti F., Barrientos A., Gajewski C.D., Kwong J.Q., Bruno C., Beal M.F., Manfredi G. In vivo regulation of oxidative phosphorylation in cells harboring a stop-codon mutation in mitochondrial DNA-encoded cytochrome c oxidase subunit I. J. Biol. Chem. 276:2001;46925-46932.
26. Beltran B., Quintero M., Garcia-Zaragoza E., O'Connor E., Esplugues J.V., Moncada S. Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signaling. PNAS. 99:2002;8892-8897.
27. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta. 1453:1999;49-62.
28. Korge P., Weiss J.N. Thapsigargin directly induces the mitochondrial permeability transition. Eur. J. Biochem. 265:1999;273-280.
29. Varbiro G., Veres B., Gallyas F., Sumegi B. Direct effect of taxol on free radical formation and mitochondrial permeability transition. Free Radic. Biol. Med. 31:2001;548-558.
30. Manning A.S., Bruyninckx C., Ramboux J., Chatelain P. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. J. Cardivasc. Pharmacol. 26:1995;453-461.
31. Takach T.J., Voigtlander J.P., Jones M., Clark R.E. Myocardial protective effect of amiodarone in hypertrophied hearts during global ischemia. Ann. Thorac. Surg. 41:1986;542-546.
32. Halmosi R., Berente Z., Osz E., Toth K., Literati-Nagy P., Sumegi B. Effect of poly-ADP-ribose-polymerase inhibitors on the ischemia-reperfusion induced oxidative cardiac injury and mitochondrial metabolism in Langendorff heart perfusion system. Mol. Pharmacol. 59:2000;1497-1505.
33. Halmosi R., Deres P., Toth A., Berente Z., Kalai T., Sumegi B., Hideg K., Toth K. 2,2,5,5-Tetramethylpyrroline-based compounds in the prevention of oxyradical-induced myocardial damage. J. Cardiovasc Pharmacol. 40:2002;854-867.
34. Di Matola T., D'Acsoli F., Fenzi G., Rossi G., Martino E., Bogazzi F., Vitale M. Amiodarone induces cytochrome c release and apoptosis through a iodine-independent mechanism. J. Clin. Endocrinol. Metab. 85:2000;4323-4330.
35. Beavis A.D. On the inhibition of the mitochondrial inner membrane anion unioporter by cationic amphiphiles and other drugs. J. Biol. Chem. 264:1989;1508-1515.
36. 2+ antagonists binding sites are associated with an inner mitochondrial membrane anion channel. Mol. Pharmacol. 38:1990;362-369.
37. Antonenko Y.N., Kinnally K.W., Tadeschi H. Identification of anion and cation pathways in the inner mitochondrial membrane by patch clamping of mouse liver mitoplast. J. Membr. Biol. 124:1991;151-158.
38. + ATPase activity in rat-brain synaptic membranes. Biochem. Biophys. Res. Commun. 129:1985;148-154.
39. Sautereau A.M., Tournaire C., Suares M., Tocanne J.F., Paillous N. Interactions of amiodarone with model membranes and amiodarone-photoinduced peroxidation of lipids. Biochem. Pharmacol. 43:1992;2559-2566.
40. Federico A., Battisti C., Manneschi L., Gaggelli E., Tassini M., Valensin G., Vivo A. Amiodarone affects membrane water permeability properties of human erythrocytes and rat mitochondria. Eur. J. Pharmacol. 304:1996;237-241.
41. Fromenty B., Fisch C., Berson A., Letteron P., Larrey D., Pessayre D. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibiton of the respiratory chain at the levels of complex I and complex II. J. Pharmacol. Exp. Ther. 255:1990;1377-1384.
42. Hostetler K.Y., Giordano J.R., Jellison E.J. In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone. Biochim. Biophys. Acta. 959:1988;316-321.
43. Evtodienko Y.V., Teplova V.V., Sidash S.S., Ichas F., Mazat J.P. Microtubule-active drugs suppress the closure of the permeability transition pore in tumor mitochondria. FEBS Lett. 393:1996;86-88.
44. Dawson T.L., Gores G.J., Nieminen A.-L., Herman B., Lemasters J.J. Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am. J. Physiol. 264:1993;C961-C967.